iifl-logo

Indegene Ltd Board Meeting

575.8
(-0.47%)
Apr 1, 2025|12:00:00 AM

Indegene CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting19 Mar 202519 Mar 2025
Disclosure under Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements)Regulations,2015
Board Meeting30 Jan 202524 Jan 2025
Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve 1. The unaudited consolidated financial results of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter December 31 2024 along with the limited review report of the Auditors thereon. 2. The unaudited standalone financial results of the Company as per INDAS for the quarter December 312024 along with the limited review report of the Auditors thereon. 3. Appointment of statutory auditor for five financial years commencing from 2025-26 and to hold such office till the conclusion of Annual General Meeting to be held for the Financial Year 2029-30. 4. Approval of allotment under ESOP Scheme 2020 RSU Scheme 2020 The unaudited consolidated financial results of the company and its subsidiaries as per [INDAS] for the quarter ended December 31, 2024 along with the Limited review report of the Auditors thereon. The unaudited standalone financial results of the company as per [INDAS] for the quarter ended December 31, 2024 along with the limited review report of the Auditors thereon. To Allot shares under ESOP 2020 plan & RSU 2020 plan. (As Per BSE Announcement Dated on: 30/01/2025) Integrated Filing (financial) for the quarter ended 31st December 2024 (As Per BSE Announcement dated on 10.02.2025)
Board Meeting15 Nov 202412 Nov 2024
Pursuant to Regulation 30 of the SEBI[LODR] Regulation, 2015, We hereby inform you that the following resolutions of Board of Directors of Indegene Limited are scheduled to be circulated on Friday, November 15, 2024. 1. To allot shares under ESOP 2020 Plan- with bonus element. 2. To allot shares under ESOP 2020 plan- Without bonus element. 3. To allot shares under RSU 2020 plan- With bonus element. 4. To allot shares under RSU 2020 Plan - Without bonus element.
Board Meeting28 Oct 202422 Oct 2024
Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 w Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of Indegene Limited at its meeting held today, i.e., October 28, 2024, has approved the following: Unaudited Standalone and Consolidated Financial Results along with limited review report of the Auditors thereon for the quarter September 30, 2024. The Financial Results along with the limited review report of the Auditors with an unmodified opinion and CFO declaration are attached herewith. The meeting of the Board of Directors commenced at 18:10 P.M. and concluded at 18:50 P.M. The above information is being made available on the website of the Company. https://www.indegene.com/ This is for your information and records (As per BSE Announcement Dated on 28/10/2024)
Board Meeting27 Sep 202427 Sep 2024
Pursuant to Regulation 30 of the SEBI(LODR),2015, we hereby inform you that the following resolutions were passed by the directors of Indegene Limited by circulation on September 27,2024:- 1) To allot shares under RSU 2020 plan - with bonus element. 2) To allot shares under ESOP 2020 plan - Without bonus element.
Board Meeting1 Aug 202424 Jul 2024
Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2024 inter alia to consider and approve Financial results for the quarter ended 30 June 2024. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of Indegene Limited at its meeting held today, i.e., August 1, 2024, has approved the following: Unaudited Standalone and Consolidated Financial Results along with limited review report of the Auditors thereon for the quarter June 30, 2024. The Financial Results along with the limited review report of the Auditors with an unmodified opinion are attached herewith. Financial results for the quarter ended 30 June 2024 - Consolidated and Standalone (As per BSE Announcement Dated on 01/08/2024) 1. Intimation on approval and amendment to the policy on silent period and code of conduct of prevention insider trading and amended code of practices and procedures for fair disclosure of unpublished price sensitive information. 2.Nomination rights under regulation 31B of SEBI[LODR] Regulation 2015. 3. Directors report and secretarial auditorss report . 4. 26th Annual general meeting, Record Date and Book Closure 5. Appointment of Scrutinizer (As per BSE Announcement Dated on 06/08/2024)
Board Meeting29 May 202421 May 2024
Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve 1. The audited consolidated financial results and statements of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter and financial year ending March 31 2024 along with the reports of the Auditors thereon; 2. The audited standalone financial results and statements of the Company as per INDAS for the quarter and financial year ending March 31 2024 along with the reports of the Auditors thereon; Audited Standalone and Consolidated Financial Results along with Auditors Report thereon for the quarter and financial year ended March 31, 2024. The Financial Results along with the Auditors Report with an unmodified opinion are attached herewith. Read less.. (As Per BSE Announcement Dated on 29.05.2024) Audited Standalone and Audited Consolidated Financial Results alongwith Auditors Report for the quarter and financial year ended March 31, 2024 (As Per BSE Announcement Dated on 30.05.2024)

Indegene: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.